BLUEBIRD STRATEGIES

Lobbying for MYOTONIC · Patient advocacy organization.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 6, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Funding for myotonic dystrophy research as part of the FY27 Congressionally Directed Medical Research Program & Peer Review Medical Research Program.

Budget/Appropriations

Myotonic dystrophy biomedical research funding

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.